BTI
CRL icon

Blue Trust Inc’s Charles River Laboratories CRL Stock Holding History

Blue Trust Inc’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$666K Buy
2,937
+361
+14% +$64.3K 0.01% 393
2026
Q1 		$444K Buy
2,576
+144
+6% +$26.7K 0.01% 515
2025
Q4 		$485K Sell
2,432
-343
-12% -$62.2K 0.01% 494
2025
Q3 		$434K Buy
2,775
+213
+8% +$33.8K ﹤0.01% 535
2025
Q2 		$389K Buy
2,562
+155
+6% +$20.7K ﹤0.01% 539
2025
Q1 		$362K Buy
2,407
+904
+60% +$152K ﹤0.01% 505
2024
Q4 		$277K Sell
1,503
-374
-20% -$72K ﹤0.01% 549
2024
Q3 		$388K Buy
1,877
+418
+29% +$86.9K 0.01% 560
2024
Q2 		$395K Buy
1,459
+234
+19% +$53K 0.01% 467
2024
Q1 		$332K Buy
1,225
+240
+24% +$57.3K ﹤0.01% 368
2023
Q4 		$193K Buy
985
+177
+22% +$34.8K ﹤0.01% 456
2023
Q3 		$170K Buy
808
+682
+541% +$140K ﹤0.01% 476
2023
Q2 		$26K Sell
126
-1,140
-90% -$227K ﹤0.01% 944
2023
Q1 		$276K Buy
1,266
+364
+40% +$82.5K ﹤0.01% 434
2022
Q4 		$178K Buy
902
+899
+29,967% +$196K ﹤0.01% 494
2022
Q3 		$1K Sell
3
-85
-97% -$18.4K ﹤0.01% 1900
2022
Q2 		$25K Buy
+88
New +$21.5K ﹤0.01% 896

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Blue Trust Inc's CRL Position: Q2 2026 in Review

Blue Trust Inc increased its Charles River Laboratories (CRL) stake by 14% in Q2 2026, buying an estimated $64.3K and bringing the position to 2,937 shares worth $666K. The position accounts for 0.01% of the portfolio, ranked #393.

Blue Trust Inc first reported a position in CRL in Q2 2022 and has held it in 17 quarters since. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Blue Trust Inc held 2,937 shares of Charles River Laboratories worth $666K as of Q2 2026.
  • Blue Trust Inc bought 361 Charles River Laboratories shares in Q2 2026, an estimated $64.3K.
  • Charles River Laboratories made up 0.01% of Blue Trust Inc's portfolio in Q2 2026, its #393 holding.
  • Blue Trust Inc first reported a position in Charles River Laboratories in Q2 2022 and has held it in 17 quarters since.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.